Among those individuals who progress from infection to illness, 5–25% present with the acute/subacute clinical form of PCM, in which Th-2 and Th-9 immune response patterns activate B-lymphocytes that produce high levels of antigen-specific IgA, IgE, and IgG4 [61]. The gene discussed is CD79A; the disease is paracoccidioidomycosis.